Verisk Analytics, Inc. (VRSK) has been one of the market's more durable data-analytics franchises, but its stock has fallen sharply over the past year. After trading as high as roughly $273.83 in the fall of 2025, the shares have since retreated to about $185.79, a decline of more than 30%. That drop has left investors asking a natural question: can VRSK climb back toward a round-number milestone like $250?
The $250 level is meaningful for several reasons. It sits just above the average 12-month analyst price target of approximately $237.71, meaning it represents a "stretch" objective that would still require renewed conviction from Wall Street. It is also a clean psychological threshold that aligns with the upper band of the company's fair-value estimates in the mid-to-high $200s.
Verisk is a leading provider of data analytics and technology to the insurance industry. Its underwriting solutions help property-and-casualty insurers with rating, pricing, and risk selection, while its claims solutions include property repair cost estimates and antifraud tools. The company has simplified its portfolio by divesting non-insurance businesses to focus on this core franchise, which generates the large majority of its revenue from recurring, subscription-based contracts.
That subscription model is a key part of the bull case. In its trailing twelve months, Verisk generated roughly $3.14 billion in revenue and about $885.5 million in net income, with gross margins near 70%. The company also pays a modest dividend of $2.00 per share, a yield of about 1.08% at recent prices.
At around $185.79, VRSK trades near the middle-to-lower end of its 52-week range of $155.94 to $273.83. The stock carries a trailing price-to-earnings (P/E) ratio near 28.6 and a forward P/E near 22.7, reflecting expectations of continued earnings growth. With a beta of about 0.66, Verisk is less volatile than the broader market, which has historically supported its reputation as a defensive, cash-generative compounder.
Several factors could support a recovery toward $250. First, Verisk's proprietary datasets are embedded directly into insurer workflows, creating meaningful switching costs and pricing power. Second, its subscription-heavy revenue base provides predictable cash flows that fund both dividends and share repurchases. Third, the company continues to invest in advanced analytics and artificial intelligence partnerships, which could reinforce its competitive position rather than undermine it.
If Verisk can sustain mid-single-digit revenue growth and expand its profit margins while demonstrating that AI enhances—rather than threatens—its offerings, investors may be willing to re-rate the stock toward its prior valuation levels.
The primary obstacle is the debate over AI disruption. Bears argue that generative AI could make it easier for insurers to build their own tools or for new competitors to enter the market, pressuring Verisk's moat and pricing. Slower organic growth and recent acquisition-related leverage also weigh on sentiment. Notably, a Delaware court in mid-2026 ordered Verisk to proceed toward completing its planned $2.35 billion acquisition of roofing software provider AccuLynx, a ruling the company disputed and may appeal—an overhang that contributed to a notable one-day share decline.
The analyst community remains generally constructive but has trimmed expectations. According to aggregated data, the consensus 12-month price target for VRSK is approximately $237.71, implying roughly 28% upside from recent levels, with individual targets ranging from about $185 to as high as $275–$320. The consensus rating stands at a "Buy." Importantly, most targets now cluster in the low-to-mid $200s, meaning a move to $250 would require the stock to exceed the average analyst forecast—a bar it cleared as recently as 2025.
From a technical-analysis perspective, the $155.94 52-week low serves as the key support level, with additional support near the $180 area where buyers have previously stepped in. On the upside, VRSK faces resistance around the $195–$200 zone, which aligns roughly with its 200-day moving average and recent trading range. Above that, the $237 consensus target and the psychologically significant $250 level represent the next major supply zones that would need to be cleared on rising volume.
At a trailing P/E near 28.6 and a forward P/E near 22.7, Verisk trades at a premium to some peers such as Equifax Inc. (EFX), reflecting the quality and recurring nature of its revenue. That premium is a double-edged sword: it supports the stock in down markets but also means any disappointment in growth or margins could trigger further multiple compression. Reaching $250 would likely require both earnings growth and a stable-to-expanding valuation multiple.
Traders monitoring whether VRSK can build toward higher levels may benefit from automated tools such as Tickeron's AI Daily Buy/Sell Signals. This product uses artificial intelligence to continuously scan thousands of stocks and ETFs, generating Buy, Sell, or Hold signals based on shifting market conditions, technical behavior, and AI-driven analysis. By surfacing opportunities and flagging changing trends more efficiently, it can help investors monitor existing positions and identify emerging setups. Explore AI Daily Buy/Sell Signals to see how AI-powered monitoring can support your trading decisions.
A move back to $250 appears achievable but not imminent. The strongest support comes from Verisk's entrenched position in insurance data analytics, its recurring revenue, and its strong free cash flow—qualities that historically commanded a premium valuation. The biggest obstacles are the unresolved AI-disruption debate, slowing organic growth, and the lingering AccuLynx acquisition overhang. For the target to become realistic, investors would likely need to see sustained revenue reacceleration, margin stability, and evidence that Verisk's data moat remains intact. Until then, the $195–$200 resistance zone and the $237 consensus target are likely to be tested before $250 comes into view.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
A.I.dvisor indicates that over the last year, VRSK has been loosely correlated with EXPO. These tickers have moved in lockstep 51% of the time. This A.I.-generated data suggests there is some statistical probability that if VRSK jumps, then EXPO could also see price increases.
| Ticker / NAME | Correlation To VRSK | 1D Price Change % | ||
|---|---|---|---|---|
| VRSK | 100% | +0.19% | ||
| EXPO - VRSK | 51% Loosely correlated | -0.18% | ||
| TRI - VRSK | 46% Loosely correlated | +1.71% | ||
| CTAS - VRSK | 46% Loosely correlated | +1.54% | ||
| ABM - VRSK | 44% Loosely correlated | +0.73% | ||
| RELX - VRSK | 44% Loosely correlated | -0.06% | ||
More | ||||
| Ticker / NAME | Correlation To VRSK | 1D Price Change % |
|---|---|---|
| VRSK | 100% | +0.19% |
| Data Processing Services industry (24 stocks) | 17% Poorly correlated | +0.27% |
| Technology Services industry (397 stocks) | -5% Poorly correlated | +0.87% |